Beijing April 24, BD Medical (Becton Dickinson), announced a $ 24 billion acquisition of supplies medical technology giant Budd Company (CR Bard), plus after the merger of its total sales of $ 13.371 billion.
The transaction has been approved by the board of directors of both companies. BD Medical will pay approximately $222.93 in cash per share of Bard's shares, plus 0.5077 shares of BD stock, which is equivalent to $317 per share based on last Friday's closing price.
According to the sales rankings of the world's newest medical device top 100 companies, when the ninth ranked BD medical team and the 24th Bard fit together, its sales may exceed Roche, Philips and Kantler before the global rush into the world. Five, second only to Medtronic, Johnson & Johnson, GE and Siemens.
BD said in a statement that after BD acquires Bard, its annual revenue in China will reach 1 billion US dollars.
BD Medical is a medical device company that started with syringe products, and then gradually transitioned to disposable medical products, such as plastic syringes, disposable needles and indwelling needles, and then extended the product line to in vitro diagnostic and biological science products. In 1994, BD officially sent a representative to establish a representative office in China to carry out business with China. In August 1995, BD invested US$25 million to establish Suzhou Pudi Medical Devices Co., Ltd. in Suzhou Industrial Park, Jiangsu, China. In 2008, BD continued to invest US$24 million for plant expansion; in 2012, BD invested another 3 In the Suzhou Industrial Park, a billion-dollar project was launched in Suzhou Industrial Park, the second production project of Suzhou Bidi Medical Devices Co., Ltd.
Nitrile Chemical Gloves,Nitrile Chemical Resistant Gloves,Green Nitirle Chemical Gloves,Tripop Heavy-Duty Nitrile Gloves
JINAN SHANDE SECURITY TECHNOLOGY CO., LTD , https://www.sdsxlb.com